Invention Grant
- Patent Title: Processes and intermediates for making a JAK inhibitor
-
Application No.: US15278283Application Date: 2016-09-28
-
Publication No.: US09718834B2Publication Date: 2017-08-01
- Inventor: Jiacheng Zhou , Yongzhong Wu , Pingli Liu
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D491/113 ; C07D487/04 ; C07D491/10
Abstract:
This invention relates to processes and intermediates for making {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, useful in the treatment of diseases related to the activity of Janus kinases (JAK) including inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Public/Granted literature
- US20170015674A1 PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR Public/Granted day:2017-01-19
Information query
